Newsfeeds - Spark Newswire

1 minute read

SciSparc Board Of Directors Authorizes Co. To Take Actions To Implement Buyback Program Of Up To $1M

Today, 4:48 PM

SciSparc Ltd. (NASDAQ:SPRC) (the "Company" or "SciSparc"), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system,

SPRC

2 minute read

FDA
News

SciSparc Announces Ethics Committee Approval to Conduct its Clinical Trial in Autism Spectrum Disorder

By Benzinga Newsdesk

Today, 4:48 PM

SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system,

SPRC

4 minute read

70 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 4:48 PM

Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares jumped 110% to $13.93 after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in relapsed pediatric low-grade glioma showed an overall response rate of 64%.

ABVC

5 minute read

Psyched: Christie’s Launches NFT Collection Supporting Psychedelic Science, Origin’s Listing On CSE Gives Retail Investors Access To Private Companies

By Natan Ponieman

Today, 4:48 PM

The world of psychedelics is getting a crossover with another category in the millennial catalog of trendy investments: NFTs.

CMNDF

2 minute read

SciSparc & Clearmind Medicine Team Up On Patent For Psychedelic Combination To Treat Cocaine Addiction

By Vuk Zdinjak

Today, 4:48 PM

SciSparc Ltd. (NASDAQ: SPRC) collaboration with Clearmind Medicine Inc. (OTCPK:CMNDF) (CSE:CMND) (FSE:CWY0) resulted in the filing of a provisional patent application related to treating cocaine addiction.

CMNDF

2 minute read

Clearmind Medicine and SciSparc Collaboration Yields Another Patent Application for Cocaine Addiction Treatment

By Charles Gross

Today, 4:48 PM

Clearmind Medicine Inc.

CMNDF

2 minute read

SciSparc To Collaborate With Polyrizon For Brain Targeting Using Intranasal Hydrogel Systems

By Benzinga Newsdesk

Today, 4:48 PM

SciSparc Ltd. (NASDAQ: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the "Company" or "SciSparc"),SciSparc Ltd.

SPRC

5 minute read

70 Biggest Movers From Friday

By Lisa Levin

Today, 4:48 PM

Gainers Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares climbed 133.6% to close at $2.50 on Friday. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for experimental narcolepsy drug.

ACB

3 minute read

41 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

Today, 4:48 PM

Gainers Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares rose 60.2% to $1.7136. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for experimental narcolepsy drug.

ACB

1 minute read

News

SciSparc Announces Pricing Of $10M Private Placement Priced At-the-Market; 3,546,100 Units At $2.82/Unit

By Bill Haddad

Today, 4:48 PM

SciSparc Ltd. (NASDAQ:SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system,

SPRC